These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34299330)

  • 21. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.
    Uhelski ML; Khasabova IA; Simone DA
    J Neurophysiol; 2015 Mar; 113(5):1501-10. PubMed ID: 25505113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ; Abdullah RA; Poklis JL; Lichtman AH; Negus SS
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M; Panlilio LV; Fadda P; Fattore L; Gamaleddin I; Le Foll B; Justinová Z; Mikics E; Haller J; Medalie J; Stroik J; Barnes C; Yasar S; Tanda G; Piomelli D; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
    Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K; Ramer R; Dithmer S; Ivanov I; Merkord J; Hinz B
    Oncotarget; 2016 Mar; 7(12):15047-64. PubMed ID: 26930716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B; Muccioli GG; Lambert DM
    Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.
    Björklund E; Blomqvist A; Hedlin J; Persson E; Fowler CJ
    PLoS One; 2014; 9(7):e103479. PubMed ID: 25078278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of FAAH confers increased stem cell migration via PPARα.
    Wollank Y; Ramer R; Ivanov I; Salamon A; Peters K; Hinz B
    J Lipid Res; 2015 Oct; 56(10):1947-60. PubMed ID: 26263913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
    Hama AT; Germano P; Varghese MS; Cravatt BF; Milne GT; Pearson JP; Sagen J
    PLoS One; 2014; 9(5):e96396. PubMed ID: 24788435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.
    Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR
    Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
    Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
    Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.
    Ravi J; Sneh A; Shilo K; Nasser MW; Ganju RK
    Oncotarget; 2014 May; 5(9):2475-86. PubMed ID: 24811863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats.
    Zubrzycki M; Zubrzycka M; Wysiadecki G; Szemraj J; Jerczynska H; Stasiolek M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells.
    Tanaka M; Yagyu K; Sackett S; Zhang Y
    Cells; 2019 May; 8(5):. PubMed ID: 31121907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
    Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.